RESEARCH TRIANGLE PARK, N.C. – January 7, 2014 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 on Thursday, February 13, 2014, before the market opens. An investor conference call to discuss the fourth quarter financial results and to provide 2014 financial guidance will be held on Thursday, February 13, 2014 at 8 a.m. EST.

The conference call will be accessible, live via webcast, through the Investor Relations section of the Quintiles website at To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.

An archived edition of the conference call will be available online at after 1 p.m. EST on Thursday, February 13th.

About Quintiles

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit


Phil Bridges, Media Relations (
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)

Karl Deonanan, Investor Relations (